Savara Announces New Employment Inducement Grant

Businesswire11/23 05:05

Savara Announces Encore Presentation of Results From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the British Thoracic Society Winter Meeting 2024

Businesswire11/22 21:05

Independent Director of Savara David Ramsay Buys 4.5% More Shares

Simply Wall St11/21 18:06

Savara Insider Bought Shares Worth $287,600, According to a Recent SEC Filing

MT Newswires11/19 01:37

Savara Downgraded at Evercore on Manufacturing Concerns for Lung Disease Candidate

Seeking Alpha11/13 23:58

Savara Is Maintained at Buy by HC Wainwright & Co.

Dow Jones11/13 22:53